Is John Hancock Multifactor Small Cap ETF (JHSC) a Strong ETF Right Now?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 02 2024
0mins
Source: NASDAQ.COM
Overview of John Hancock Multifactor Small Cap ETF: Launched in 2017, the John Hancock Multifactor Small Cap ETF (JHSC) offers exposure to small-cap blend stocks and aims to outperform traditional market cap weighted indexes through smart beta strategies, with a current asset size of over $496 million and an expense ratio of 0.42%.
Performance and Comparison with Other ETFs: JHSC has shown a return of approximately 24.27% over the past year, but investors may also consider lower-cost alternatives like the iShares Russell 2000 ETF and iShares Core S&P Small-Cap ETF, which have significantly lower expense ratios and larger asset bases.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GNRC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GNRC
Wall Street analysts forecast GNRC stock price to fall
14 Analyst Rating
11 Buy
3 Hold
0 Sell
Strong Buy
Current: 247.790
Low
184.00
Averages
207.67
High
240.00
Current: 247.790
Low
184.00
Averages
207.67
High
240.00
About GNRC
Generac Holdings Inc. is a global designer, manufacturer, and provider of a range of energy technology solutions. It offers power generation equipment, energy storage systems, energy management devices and solutions, and other power products and services serving residential, commercial, data center, telecom, and industrial markets. Its segments include Domestic and International. Domestic segment includes its business and all historical acquisitions based in the United States and Canada. International segment includes all historical acquisitions not based in the United States and Canada. It has developed a line of energy storage systems for use in residential solar-plus-storage applications, as well as microinverters for residential solar energy production. It has a selection of energy monitoring and management devices and controls that serve as the central hub for its residential and C&I energy ecosystems. It designs and manufactures other power products, including light towers.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Stock Performance: Generac's stock has surged 82% year-to-date, showcasing strong investor confidence in its growth potential, despite not being a traditional AI stock, indicating a significant market interest.
- Sales Growth: The company's commercial and industrial segment reported a 28% sales increase in Q1, primarily driven by data center demand, with 2026 guidance raised and a backlog exceeding $700 million, reflecting robust market demand.
- Risk Considerations: While current performance is positive, the market has high expectations for Generac's future; failure to meet these could lead to stock price corrections, especially as concerns grow over the AI trade's potential overextension.
- Long-Term Growth Potential: Generac has achieved a compound annual growth rate of approximately 14% from 2000 to 2025, with data center backup power being deemed
See More
- Significant Growth: Generac's anticipated performance in 2026 is expected to surge due to skyrocketing demand from data centers, with a 28% year-over-year sales increase in Q1 indicating robust performance in its commercial and industrial segments, potentially driving stock price upward.
- Optimistic Market Outlook: Although Generac's stock has nearly doubled over the past 12 months and is trading near 52-week highs, market observers argue that future returns may be limited, prompting investors to focus on upcoming performance to mitigate risks.
- Data Center Demand Driver: The demand for backup power in data centers is deemed
See More
- Upgrade Impact: Jefferies upgraded Generac's rating from 'Hold' to 'Buy' and raised its price target from $239 to $302, reflecting confidence in the company's potential to secure contracts in the data center sector, which is expected to drive future performance growth.
- Growing Market Demand: With the rising demand for AI infrastructure, the adoption of Generac's Baudouin engines in large data centers is increasing, and analysts believe the company is nearing a pivotal moment in winning significant business from large-scale data center operators, potentially leading to substantial business growth.
- Strong Financial Performance: Generac's recent Q1 2026 earnings report revealed revenue of $1.06 billion, a 12.4% year-over-year increase, with adjusted earnings per share of $1.80, exceeding analyst expectations by over 35%, indicating a significant improvement in the company's profitability metrics.
- Stock Volatility Analysis: Despite a year-to-date gain of 89.2%, Generac's stock has experienced significant volatility, with 17 moves greater than 5% in the past year, indicating that the market considers the current news impactful but not fundamentally altering its perception of the business.
See More
- Market Performance: The S&P 500 is nearing 7,500, on track for its eighth consecutive week of gains, reflecting strong market performance driven by sectors like healthcare and information technology, indicating investor confidence in economic recovery.
- Stock Dynamics: Merck leads the healthcare sector with encouraging trial results, while Dell's stock surges over 16%, showcasing a robust rebound in tech stocks that may attract more investor interest in these sectors' growth potential.
- Arm Holdings Surge: Arm Holdings rallies nearly 50% this week, and despite trimming shares on Monday, it still locked in a 20% gain, highlighting its significance and growth potential within the portfolio, reflecting optimistic market expectations for its future performance.
- Starbucks AI Project Adjustment: Starbucks has ended an AI program for automating inventory accounting, which may impact its $2 billion cost savings target; however, CEO Brian Niccol is set to discuss this goal at next week's conference, indicating the company's ongoing focus on cost control during its turnaround efforts.
See More
- Stock Price Surge: Generac (GNRC) rose 7.5% in Friday's trading after Jefferies upgraded its rating from Hold to Buy and raised the price target from $239 to $302, reflecting strong market confidence in its growth prospects.
- Data Center Contract Outlook: Jefferies analysts highlighted that Generac is nearing a critical moment in securing contracts with major hyperscaler data centers, particularly against the backdrop of rapid AI infrastructure development, indicating robust market demand.
- Potential Contract Opportunities: Generac is close to finalizing an agreement with its first hyperscaler client, having disclosed a non-binding $600 million notice to proceed, and despite fierce market competition, analysts are increasingly confident in the management's execution capabilities.
- Increased Market Acceptance: As Baudouin engines find their way into hyperscaler configurations, Generac's products are gaining acceptance in the market, and analysts believe that after a 12% correction, the stock still has significant upside potential.
See More
- Lenovo's Performance Boost: Lenovo reported an 84% increase in AI-related revenue for Q4, leading to a nearly 20% surge in its stock price, which also propelled Dell and HP shares up over 15%, reflecting strong market demand and competitive positioning in AI technology.
- Estee Lauder's Stock Recovery: Estee Lauder's shares rose 10% despite ending merger talks with Puig, indicating robust market performance and a solid position in the cosmetics industry.
- Workday's Strong Results: Workday's stock jumped nearly 4% after posting better-than-expected earnings and raising its full-year margin outlook, showcasing its growth potential in finance and HR software.
- Merck's Drug Breakthrough: Merck's lung cancer treatment, developed in partnership with Kelun-Biotech, demonstrated a 65% reduction in tumor progression risk in a phase 3 study, resulting in a nearly 5% increase in stock price, reinforcing its competitive edge in oncology.
See More











